"Cocaine, meth, nicotine, morphine — we did the same studies with 18-MC, and it worked as well or better than ibogaine," Glick says. "We also have data that it will be useful in treating obesity. In animals, it blocks their intake of sweet and fatty foods without affecting their nutrient intake."
Glick and his cohorts have yet to determine whether their synthetic ibogaine has psychedelic properties. The rats, after all, aren't talking. "You look at an animal given ibogaine, and you can't tell if they're hallucinating. But they look positively strange," he says. "You give them 18-MC, and you can't really tell. But we hope when it gets to people, it won't produce hallucinatory effects."
Ibogaine has helped addicts kick meth and heroin. Is it the trip that does the trick?